Qube Research & Technologies (QRT)
SKYE icon

Qube Research & Technologies (QRT)’s Skye Bioscience SKYE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,658
Closed -$65.5K – 4166
2025
Q3 		$65.5K Sell
16,658
-35,546
-68% -$134K ﹤0.01% 3138
2025
Q2 		$218K Buy
+52,204
New +$108K ﹤0.01% 2894

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SKYE Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 16,658 shares — an estimated $65.5K sold.

Qube Research & Technologies (QRT) first reported a position in SKYE in Q2 2025 and held it in 2 quarters. The position peaked at $218K in Q2 2025. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 16,658 Skye Bioscience shares in Q4 2025, an estimated $65.5K.
  • Qube Research & Technologies (QRT) first reported a position in Skye Bioscience in Q2 2025 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Skye Bioscience position peaked at $218K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.